Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous Products

* Novartis obtains rights to develop and commercialize subcutaneous formulations for multiple products utilizing ALT-B4 * Alteogen's fourth licensing agreement signed this year further accelerating the expansion of the Hybrozyme™ platform DAEJEON, South Korea, Sept. 2, 2026 /PRNewswire/ -- Al...

2026-09-02 19:00 2846

NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept Study in Acute Spinal Cord Injury

Round led by Neurimmune and Pureos, with participation from existing and new investors; complemented by non-dilutive funding from the Swiss Paraplegic Foundation and Wings for Life - Spinal Cord Research Foundation. SCHLIEREN, Switzerland, Sept. 2, 2026 /PRNewswire/ -- NovaGo Therapeutics AG, a ...

2026-09-02 18:00 2486

Norroy Bioscience Initiates Pivotal Phase III Clinical Trial of 177Lu-NYM032, a PSMA-Targeted Radioligand Therapy for mCRPC

WUXI, China, Sept. 2, 2026 /PRNewswire/ -- NORROY BIOSCIENCE (NORROY), a clinical-stage biotechnology company focused on innovative targeted radiopharmaceuticals, announced that it has received regulatory clearance from China's National Medical Products Administration (NMPA) to initiate a pivotal...

2026-09-02 17:00 1695

BTL Establishes New Laser Division and Introduces EXOLASE ONE® - The World's First Fused Erbium Laser

Proprietary technology fuses multiple wavelengths into a single beam to set a new standard of care in laser facial rejuvenation. PRAGUE, Sept. 2, 2026 /PRNewswire/ -- BTL, a global leader in advanced energy-based medical and aesthetic technologies, today announced a major milestone in its corpor...

2026-09-02 16:00 1715

BTL Establishes New Laser Division and Introduces EXOLASE ONE® - The World's First Fused Erbium Laser

Delays Before Patients Reach Stroke Centers Still Hinder Timely Treatment Across Southeast Asia, Siemens Healthineers Report Finds

New research commissioned by Siemens Healthineers shows transportation delays, slow reporting processes as leading barriers to timely stroke diagnosis. * Stronger referral networks, public awareness, AI-enabled diagnostics, coordinated care are key to strengthening stroke system readiness acros...

2026-09-02 15:00 4476

Singapore has cut stroke mortality by up to six-fold since the 1990s, but public awareness remains the final hurdle, new report finds

Singaporean experts call for renewed public education on the FAST warning signs and continued investment in specialist staffing to sustain the country's world-leading stroke outcomes. SINGAPORE, Sept. 2, 2026 /PRNewswire/ -- Singapore has cut stroke mortality by up to six-fold since the 1990s[1]...

2026-09-02 15:00 4500

Despite nationwide basic stroke treatment coverage, delays accessing advanced stroke care in Vietnam vary by region, new report finds

Patients in Vietnam's Southwest region and Mekong Delta can travel up to ten hours for advanced stroke care; Vietnamese experts point to a public-private model in Can Tho as a way to close that gap. HO CHI MINH CITY, Vietnam, Sept. 2, 2026 /PRNewswire/ -- Delays occurring before patients reach a...

2026-09-02 15:00 3977

Workforce shortages and limited public hospital capacity remain major barriers to stroke care in the Philippines, new report finds

Filipino experts call for equipping more public hospitals with advanced imaging technology, stronger EMS infrastructure and greater investment in specialist training to close these gaps MANILA, Philippines, Sept. 2, 2026 /PRNewswire/ -- Workforce shortages and limited public hospital capacity re...

2026-09-02 15:00 4432

Delays before patients reach stroke centres remain a major barrier to timely treatment in Malaysia, new report finds

Malaysia experts call for better public awareness of stroke symptoms, standardised hospital imaging protocols and expanded access to specialist care beyond major urban centres KUALA LUMPUR, Malaysia, Sept. 2, 2026 /PRNewswire/ -- Delays occurring before patients reach stroke centres remain a maj...

2026-09-02 15:00 4576

"From Canine Fat Tissue to Insulin-Producing Cells": Chula Veterinary Researchers Offer New Hope for Diabetes Treatment in Pets

While diabetes is commonly associated with humans, the disease also affects dogs and cats. Its impact on the quality of life of both pets and their owners is often greater than many people realize. BANGKOK, Sept. 2, 2026 /PRNewswire/ -- In dogs, diabetes is similar to Type 1 diabetes in humans, ...

2026-09-02 14:23 2938

Smartee Expands Pediatric Orthodontic Education Initiatives in Asia Pacific Through Clinical Exchange

SINGAPORE, Aug. 31, 2026 /PRNewswire/ -- Smartee Denti-Technology recently brought together dental professionals for the Smartee Kinder & Teen Workshop, an educational program focused on the clinical assessment and management of growing patients. Held under the theme "Children's Early Orthodonti...

2026-09-02 10:38 2264

Smartee Expands Pediatric Orthodontic Education Initiatives in Asia Pacific Through Clinical Exchange

HEC Group Enters Strategic Partnerships in Macau to Advance the Internationalization of Cordyceps Sinensis

MACAU, Sept. 2, 2026 /PRNewswire/ -- HEC Group has entered into strategic partnerships with MCCY Science & Greater Health Manufactory (operating regionally as Seed Scientific Research International Limited) and Longtai Health to strengthen the production, commercialization and international deve...

2026-09-02 10:00 2188

HEC Group Enters Strategic Partnerships in Macau to Advance the Internationalization of Cordyceps Sinensis

Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to participate in trial for innovative mapping and pulsed field ablation system

AUSTIN, Texas, Sept. 2, 2026 /PRNewswire/ -- The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first facility in the nation to participate in a clinical trial to evaluate the safety and effectiveness of a next-generation mapping and pulsed field ablat...

2026-09-02 09:37 2132

Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway

* The Phase 3 BiPASS™ study of Illuccix® and Gozellix® for prostate cancer imaging in the pre-biopsy setting has completed enrollment of 350 patients. * Telix has positively engaged with the FDA on a New Drug Application (NDA) pathway in the U.S. that would support new product reimbursement an...

2026-09-02 09:27 1663

Zepp Health Corporation Reports Second Quarter of 2026 Unaudited Financial Results

MILPITAS, Calif., Sept. 1, 2026 /PRNewswire/ -- Zepp Health Corporation (NYSE: ZEPP) ("Zepp", the "Company" or "we") today announced its unaudited financial results for the second quarter of 2026. Second Quarter of 2026 Financial and Operating Highlights: * Revenue reached US$63.5 million, rep...

2026-09-02 09:00 4994

Haier Biomedical Highlights Automated Biostorage and Connected Pharma Solutions at ISPE Singapore 2026

Haier Biomedical Accelerates Its Transformation into an Intelligent Biopharmaceutical Infrastructure Platform at ISPE Singapore 2026 SINGAPORE, Sept. 1, 2026 /PRNewswire/ -- Haier Biomedical (SHA: 688139) showcased a portfolio of automated and digital solutions sp...

2026-09-01 22:50 2928

Haier Biomedical Highlights Automated Biostorage and Connected Pharma Solutions at ISPE Singapore 2026

Super MOXI® by Sciton Ushers in a New Era of Head-to-Toe Skin Revitalization

PALO ALTO, Calif., Sept. 1, 2026 /PRNewswire/ -- Sciton Inc., a pioneer and leader in medical and aesthetic laser and light-based technologies, today announced the launch of Super MOXI® with High Density (HD) Delivery™, a major evolution of its award-winning MOXI® laser that brings new speed, ver...

2026-09-01 21:10 2313

Suki Named a Transformational Innovation Leader in Ambient Clinical Intelligence by Frost & Sullivan

2026 recognition highlights Suki's innovation, clinical quality and measurable impact as Ambient Clinical Intelligence expands across the enterprise SAN ANTONIO, Sept. 1, 2026 /PRNewswire/ -- Suki

2026-09-01 21:00 1578

Simcere Zaiming Enters Exclusive License Agreement with Roche for SIM0660 Global Development

NANJING, China, Sept. 1, 2026 /PRNewswire/ -- Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group (2096.HK) today announced that it has entered into an exclusive global licensing agreement with Roche for the development and commercialization of SIM0660, a tri-specific antibody targeting...

2026-09-01 20:28 2768

Time is Running Out to Submit a Claim in the Asbestos Corporation Limited insolvency proceedings

The deadline is September 10, 2026. NEW YORK, Sept. 1, 2026 /PRNewswire/ -- The following statement is being issued by Kroll Restructuring Administration and Raymond Chabot Inc. regarding the Asbestos Corporation Limited insolvency proceedings. With less than one month remaining before the Septe...

2026-09-01 20:13 2195

1 2 3 456 7 8 ... 849